Influenza
RSSArticles
-
Infection guidelines reach beyond hospital
-
Scientific analysis can detect endemic TB
-
Welcome to Jurassic Park: Reptile-Associated Salmonellosis
-
Self-Use of Rapid Tests for Malaria Diagnosis by Tourists Poses Difficulties
-
Hepatitis E: A Synopsis of Recent Publications and Presentations
-
Pharmacology Update: Influenza Virus Vaccine Live, Intranasal (FluMist)
The FDA has approved the first nasally administered flu vaccine. This cold-adapted, temperature sensitive, attenuated, trivalent vaccine is manufactured by MedImmune Vaccine, Inc. and marketed by MedImmune and Wyeth under the name FluMist. The nasal flu vaccine should be available this fall.